Companies: 10,758     total market cap: โ‚ฌ113.193 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novo Nordisk
NVO
#102
Rank
โ‚ฌ139.75 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
31,24ย โ‚ฌ
Share price
-0.99%
Change (1 day)
-51.13%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚ฌ18.27 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚ฌ47.70 Billion. , an increase over its 2024 earnings that were of โ‚ฌ17.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ18.17 B6.28%
2024 โ‚ฌ17.09 B28.01%
2023 โ‚ฌ13.35 B57.81%
2022 โ‚ฌ8.46 B5.24%
2021 โ‚ฌ8.04 B12.38%
2020 โ‚ฌ7.15 B13.11%
2019 โ‚ฌ6.32 B-3.45%
2018 โ‚ฌ6.55 B1.88%
2017 โ‚ฌ6.43 B4.3%
2016 โ‚ฌ6.16 B10.32%
2015 โ‚ฌ5.58 B7.47%
2014 โ‚ฌ5.20 B3.4%
2013 โ‚ฌ5.03 B19.09%
2012 โ‚ฌ4.22 B15.58%
2011 โ‚ฌ3.65 B16.58%
2010 โ‚ฌ3.13 B25.66%
2009 โ‚ฌ2.49 B10.68%
2008 โ‚ฌ2.25 B55.82%
2007 โ‚ฌ1.44 B7.02%
2006 โ‚ฌ1.35 B19.05%
2005 โ‚ฌ1.13 B10.55%
2004 โ‚ฌ1.02 B
2002 โ‚ฌ0.70 B-14.39%
2001 โ‚ฌ0.82 B-52.82%
2000 โ‚ฌ1.74 B250%
1999 โ‚ฌ0.49 B31.21%
1998 โ‚ฌ0.38 B34.31%
1997 โ‚ฌ0.28 B11.46%
1996 โ‚ฌ0.25 B9.03%
1995 โ‚ฌ0.23 B-3.15%
1994 โ‚ฌ0.24 B-0.67%
1993 โ‚ฌ0.24 B45.38%
1992 โ‚ฌ0.16 B-13.81%
1991 โ‚ฌ0.19 B37.12%
1990 โ‚ฌ0.14 B-0.79%
1989 โ‚ฌ0.14 B26.2%
1988 โ‚ฌ0.11 B24.97%
1987 โ‚ฌ90.19 M-0.9%
1986 โ‚ฌ91.01 M-7.78%
1985 โ‚ฌ98.7 M24.87%
1984 โ‚ฌ79.04 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ8.83 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ22.30 B 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.67 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ8.08 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com